XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity - Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 9 Months Ended 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Number of Shares    
Beginning balance (in shares) | shares 36,576  
Options granted (in shares) | shares 1,966  
Options exercised (in shares) | shares (8,536)  
Options forfeited or expired (in shares) | shares (652)  
Ending balance (in shares) | shares 29,354 36,576
Vested and exercisable, at end of period (in shares) | shares 8,755  
Vested and expected to vest, at end of period (in shares) | shares 27,017  
Weighted-Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 2.80  
Granted (in dollars per share) | $ / shares 12.56  
Exercised (in dollars per share) | $ / shares 1.09  
Forfeited or expired (in dollars per share) | $ / shares 3.14  
Ending balance (in dollars per share) | $ / shares 3.94 $ 2.80
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares 1.34  
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares $ 3.80  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Average remaining contractual term, outstanding 7 years 8 months 26 days 7 years 10 months 9 days
Average remaining contractual term, vested and exercisable at period end 5 years 11 months 26 days  
Average remaining contractual term, vested and expected to vest at period end 7 years 7 months 20 days  
Aggregate intrinsic value, outstanding | $ $ 1,355,890 $ 357,366
Aggregate intrinsic value, vested and exercisable at period end | $ 427,159  
Aggregate intrinsic value, vested and expected to vest at period end | $ $ 1,251,699